Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
12/23/1997 | CA1339595C New antibiotics of the mureidomycin group, their preparation, and their therapeutic use |
12/18/1997 | WO1997047770A1 Novel anti-hiv ribozymes |
12/18/1997 | WO1997047752A1 Chitinase materials and methods |
12/18/1997 | WO1997047751A1 Human dnase i hyperactive variants |
12/18/1997 | WO1997047744A2 T-cell selective interleukin-4 agonists |
12/18/1997 | WO1997047742A1 Hr-1 receptor |
12/18/1997 | WO1997047738A1 Cyclic lipopeptide acylase |
12/18/1997 | WO1997047654A1 Human monoclonal antibodies to the hepatitis b surface antigen |
12/18/1997 | WO1997047653A1 Human monoclonal antibody against hepatitis b virus surface antigen (hbvsag) |
12/18/1997 | WO1997047651A1 Modified factor vii |
12/18/1997 | WO1997047648A1 T cell epitope peptide |
12/18/1997 | WO1997047644A1 T cell antigen receptor peptides |
12/18/1997 | WO1997047643A1 Cathepsin k gene |
12/18/1997 | WO1997047642A1 Cathepsin k gene |
12/18/1997 | WO1997047358A1 Synthetic hepatitis c genes |
12/18/1997 | WO1997047329A2 Radiopharmaceutical compositions capable of localizing at sites of thrombus |
12/18/1997 | WO1997047326A1 INHIBITION OF Ii SYNTHESIS |
12/18/1997 | WO1997047325A1 New composition and methods |
12/18/1997 | WO1997047321A1 Use of chimeric vaccinia virus complement control proteins to inhibit complement |
12/18/1997 | WO1997047319A1 Uses of a chemokine receptor for inhibiting hiv-1 infection |
12/18/1997 | WO1997047318A1 Uses of a chemokine receptor for inhibiting hiv-1 infection |
12/18/1997 | WO1997047317A1 Combination of a somatostatin analogue and a rapamycin |
12/18/1997 | WO1997047316A1 Screening methods for compounds useful in the regulation of body weight |
12/18/1997 | WO1997047315A1 Method of stimulating cilia |
12/18/1997 | WO1997047313A1 Total synthesis of bacitracin polypetides |
12/18/1997 | WO1997047312A1 Novel heparin binding peptides |
12/18/1997 | WO1997047307A1 Use of histone deacetylase inhibitors to activate transgene expression |
12/18/1997 | WO1997047293A1 Use of preparations containing opiate antagonists and agonists for the prevention and therapeutic treatment of migraines |
12/18/1997 | WO1997047283A1 Combination of acid protease enzymes and acidic buffers and uses thereof |
12/18/1997 | WO1997047271A2 Cellular vaccines and immunotherapeutics and methods for their preparation |
12/18/1997 | WO1997047202A1 Antifungal compositions |
12/18/1997 | WO1997040148A3 Peptide antagonists derived from the transmembrane domains of g protein-coupled receptors |
12/18/1997 | WO1997035982A3 Monocyte chemotactic protein-5 materials and methods |
12/18/1997 | WO1997035015A3 Tyrosine-phosphatase-related protein |
12/18/1997 | WO1997034627A3 Protection of hemopoietic cells during chemotherapy or radiotherapy |
12/18/1997 | WO1997029183A3 Methods and compositions for transforming dendritic cells and activating t cells |
12/18/1997 | DE19623950A1 Pharmazeutische Zubereitung in Form von Liposomen Pharmaceutical composition in the form of liposomes |
12/18/1997 | CA2258858A1 Novel anti-hiv ribozymes |
12/18/1997 | CA2258082A1 Cellular vaccines and immunotherapeutics and methods for their preparation |
12/18/1997 | CA2257991A1 Uses of a chemokine receptor for inhibiting hiv-1 infection |
12/18/1997 | CA2257864A1 Fungicidal composition for treatment of plant bulbs |
12/18/1997 | CA2257857A1 Screening methods for compounds useful in the regulation of body weight |
12/18/1997 | CA2257856A1 Radiopharmaceutical compositions capable of localizing at sites of thrombus |
12/18/1997 | CA2257829A1 Chitinase materials and methods |
12/18/1997 | CA2257614A1 Novel heparin binding peptides |
12/18/1997 | CA2257137A1 Synthetic hepatitis c genes |
12/18/1997 | CA2256761A1 Modified factor vii |
12/18/1997 | CA2256459A1 T-cell selective interleukin-4 agonists |
12/18/1997 | CA2208581A1 Substituted benzyl derivatives of polyalkylene-polyamines and their use in cosmetic and pharmaceutical compositions |
12/17/1997 | EP0812916A2 Cathepsin k gene |
12/17/1997 | EP0812913A2 HR-1 receptor, a receptor of the cytokine receptors family |
12/17/1997 | EP0812858A1 Process for the preparation of a composition containing factor VIII |
12/17/1997 | EP0812857A1 Irreversible HIV protease inhibitors, compositions containing same and process for the preparation thereof |
12/17/1997 | EP0812839A1 Irreversible HIV protease inhibitors, compositions containing same and process for the preparation thereof |
12/17/1997 | EP0812593A1 Vaccine compositions containing 3-0 deacylated monophosphoryl lipid a |
12/17/1997 | EP0812421A1 Anti dna antibody detection involving telomeric dna sequence recognition and binding |
12/17/1997 | EP0812362A1 A plasmid for expressing modified recombinant proteins in a bacterial system |
12/17/1997 | EP0812361A1 A method for expressing modified recombinant proteins in a bacterial system |
12/17/1997 | EP0812360A1 Human geranylgeranyl pyrophosphate synthetase |
12/17/1997 | EP0812357A1 A method for making heteromultimeric polypeptides |
12/17/1997 | EP0812355A2 Agent for treating tumours and other hyperplasia |
12/17/1997 | EP0812353A2 Prostaglandin receptor dp |
12/17/1997 | EP0812352A1 Redirection of cellular immunity by protein-tyrosine kinase chimeras |
12/17/1997 | EP0812333A1 Bispecific antibody effective to treat b-cell lymphoma and cell line |
12/17/1997 | EP0812332A1 AN IMMUNOINTERACTIVE MOLECULE WHICH BINDS THE $i(TIE)2/TEK RECEPTOR EXTRACELLULAR DOMAIN |
12/17/1997 | EP0812331A1 Mhc-antigen complexes for detecting and purifying antigen-specific t cells |
12/17/1997 | EP0812330A2 Peptidyl compounds comprising an itim motif which regulate hematopoietic function and their use |
12/17/1997 | EP0812329A1 Human g-protein coupled receptor |
12/17/1997 | EP0812327A1 Protein phosphatase inhibitor |
12/17/1997 | EP0812212A1 Compositions for the delivery of antigens |
12/17/1997 | EP0812210A1 Compositions and methods for enhancing the growth of hair and restoring hair color |
12/17/1997 | EP0812209A1 Cochleate phospholipids in drug delivery |
12/17/1997 | EP0812208A1 Pharmaceutical compositions for controlled release of soluble receptors |
12/17/1997 | EP0812207A1 Morphogen-induced dentine regeneration |
12/17/1997 | EP0812206A1 Method for stimulating an immune response |
12/17/1997 | EP0812205A1 Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
12/17/1997 | EP0812204A1 Codominance-mediated toxins |
12/17/1997 | EP0812203A1 Inhibitors of geranylgeranyl-protein transferase |
12/17/1997 | EP0812202A1 Galectin-8 and galectin-8-like proteins and dna molecules coding therefor |
12/17/1997 | EP0656902B1 Peptide lung surfactants and therapeutic combinations |
12/17/1997 | EP0656789B1 Method for treating a lfa-1-mediated disorder |
12/17/1997 | EP0651649B1 Granulocyte colony-stimulating factor solution delivery method |
12/17/1997 | EP0625908B1 Antidote for hirudin and synthetic thrombin inhibitors |
12/17/1997 | EP0612251B1 Stabilised antibodies |
12/17/1997 | EP0607332B1 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction |
12/17/1997 | EP0557535B1 HUMAN MONOCLONAL ANTIBODY AGAINST GLYCOPROTEIN IIb/IIIa |
12/17/1997 | EP0546013B1 Glucagon analogs with asp-9 replacements or deletions |
12/17/1997 | EP0540599B1 Adoptive immunotherapy with interleukin-7 |
12/17/1997 | EP0533872B1 Use of apotransferrin which has accumulated zinc or copper ions to combat the toxic action of endotoxin |
12/17/1997 | EP0515550B1 Heparin neutralization with platelet factor 4 |
12/17/1997 | EP0458901B1 Inhibiting transformation of cells having elevated purine metabolic enzyme activity |
12/17/1997 | CN1168156A Staphylokinase derivs. |
12/17/1997 | CN1168143A Antitumor agents isolated from intestinal mucosa, method for their isolation and their application |
12/17/1997 | CN1168142A Novel peptides, their production and use |
12/17/1997 | CN1167827A Negative related gene of large intestine cancer |
12/17/1997 | CN1167777A Interferon conjugates |
12/17/1997 | CN1036715C Cyclic peptide deriv. antifungal agents, and process for preparation thereof, and medicinal preparation contg. it |
12/16/1997 | USRE35694 Polypeptide cartilage-inducing factors found in bone |
12/16/1997 | US5698687 Rna molecule containing modified nucloside |
12/16/1997 | US5698686 Yeast telomerase compositions |